Skip to main content
. Author manuscript; available in PMC: 2009 Sep 11.
Published in final edited form as: Peptides. 2007 May 6;28(9):1883–1890. doi: 10.1016/j.peptides.2007.04.017

Figure 2.

Figure 2

MTT assay. The ability of varying doses of (A-NL-K)VIP-L2-CPT (■) and (A-NL-K)VIP (◆) to inhibit MCF7 proliferation was determined. The mean value ± S.D. of 8 determinations is indicated; p < 0.05; * using Student’s t-test. This experiment is representative of 2 others.